SCHEMBL6649092

SCHEMBL6649092

CC(C)c1ccncc1-c1nc(-c2ccc(C#N)cc2)cs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.50
CYP1A1 P04798 1/20 0.49
CYP1B1 Q16678 1/20 0.49
CDC25A P30304 1/20 0.49
CDC25B P30305 1/20 0.49
CDC25C P30307 1/20 0.49
KDM4E B2RXH2 6/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 1/20 0.44
CYP19A1 P11511 2/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
AR P10275 3/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
EIF4E P06730 1/20 0.40
KMT2A Q03164 1/20 0.40
GABRA1 P14867 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648507 0.87 KDM4E (0.53) KDM4ERAB9ASMN1; SMN2NPC1CYP19A1
SCHEMBL6647162 0.84 KDM4E (0.61) KDM4ERAB9ASMN1; SMN2NPC1CYP19A1
SCHEMBL6649082 0.84 KDM4E (0.61) GAAKDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL6651724 0.84 GAA (0.57) GAACYP1A1CYP1B1CDC25ACDC25B
SCHEMBL6647407 0.83 KDM4E (0.59) KDM4ERAB9ASMN1; SMN2NPC1CYP19A1
SCHEMBL6628490 0.81 CYP19A1 (0.58) CYP1A1CYP1B1CDC25ACDC25BKDM4E
SCHEMBL6646446 0.81 KDM4E (0.55) KDM4ERAB9ASMN1; SMN2NPC1CYP19A1
SCHEMBL6649095 0.80 GAA (0.49) GAACYP1A1CYP1B1CDC25ACDC25B
SCHEMBL6648609 0.79 CYP19A1 (0.44) KDM4ERAB9ASMN1; SMN2NPC1CYP19A1
SCHEMBL6626301 0.78 CDC25A (0.49) GAACYP1A1CYP1B1CDC25ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed